Cutler Group’s Clover Health Investments CLOV Stock Holding History

Cutler Group’s Portfolio CLOV Stock Details CLOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,300	Closed	-$1K	–	2444
2023 Q4	$1K	Buy	+1,300	New	+$1.28K	﹤0.01%	3283
2023 Q2	–	Sell	-26,600	Closed	-$5K	–	3641
2023 Q1	$5K	Buy	26,600 +15,000	+129%	+$16.4K	﹤0.01%	2700
2022 Q4	$66K	Sell	11,600 -500	-4%	-$667	0.01%	1401
2022 Q3	$62K	Buy	12,100 +400	+3%	+$1.05K	﹤0.01%	1747
2022 Q2	$55K	Sell	11,700 -59,900	-84%	-$159K	﹤0.01%	1878
2022 Q1	$200K	Sell	71,600 -8,500	-11%	-$24.6K	0.01%	1190
2021 Q4	$291K	Sell	80,100 -3,100	-4%	-$19K	0.01%	1061
2021 Q3	$373K	Sell	83,200 -211,800	-72%	-$1.81M	0.02%	949
2021 Q2	$979K	Buy	295,000 +200,100	+211%	+$1.97M	0.05%	455
2021 Q1	$345K	Buy	94,900 +7,900	+9%	+$89.2K	0.02%	928
2020 Q4	$35K	Buy	+87,000	New	+$969K	﹤0.01%	2251

Other funds holding CLOV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

JAM

Jupiter Asset Management London, United Kingdom $18.8B AUM 29.2% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Cutler Group's CLOV Position: Q1 2024 in Review

Cutler Group reduced its Clover Health Investments (CLOV) stake by 1.6% in Q1 2024, selling an estimated $268 and leaving 18,000 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #1139.

Cutler Group first reported a position in CLOV in Q4 2020 and has held it in 14 quarters since. The position peaked at $969K in Q3 2021. 137 funds tracked by Wall St. Rank hold CLOV as of Q1 2024.

Cutler Group held 18,000 shares of Clover Health Investments worth $14K as of Q1 2024.
Cutler Group sold 294 Clover Health Investments shares in Q1 2024, an estimated $268.
Clover Health Investments made up ﹤0.01% of Cutler Group's portfolio in Q1 2024, its #1139 holding.
Cutler Group first reported a position in Clover Health Investments in Q4 2020 and has held it in 14 quarters since.
Cutler Group's Clover Health Investments position peaked at $969K in Q3 2021.
137 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.